MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP–parkinsonism
Open Access
- 20 September 2016
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 87 (12) , 1266-1273
Abstract
Objective: To identify a biomarker for predicting the appearance of vertical supranuclear gaze palsy (VSGP) in patients affected by progressive supranuclear palsy–parkinsonism (PSP-P). Methods: Twenty-four patients with PSP-P were enrolled in the current study. Patients were clinically followed up every 6 months until the appearance of VSGP or the end of the follow-up (4 years). Participants underwent MRI at baseline and at the end of follow-up. Magnetic resonance parkinsonism index (MRPI), an imaging measure useful for diagnosing PSP, was calculated. Results: Twenty-one patients with PSP-P completed follow-up, and 3 patients dropped out. Eleven of 21 patients with PSP-P developed VSGP after a mean follow-up period of 28.5 months (range 6–48 months), while the remaining 10 patients with PSP-P did not develop VSGP during the 4-year follow-up period. At baseline, patients with PSP-P who later developed VSGP had MRPI values significantly higher than those of patients not developing VSGP without overlapping values between the 2 groups. MRPI showed a higher accuracy (100%) in predicting VSGP than vertical ocular slowness (accuracy 33.3%) or postural instability with or without vertical ocular slowness (accuracy 71.4% and 42.9%, respectively). Conclusions: Our study demonstrates that MRPI accurately predicted, on an individual basis, the appearance of VSGP in patients with PSP-P, thus confirming clinical diagnosis in vivo.Keywords
This publication has 35 references indexed in Scilit:
- Fifty years of progressive supranuclear palsyJournal of Neurology, Neurosurgery & Psychiatry, 2013
- Small-vessel disease is associated with poor long-term poststroke survivalNature Reviews Neurology, 2011
- Imaging differentiates progressive supranuclear palsy from Parkinson diseaseNature Reviews Neurology, 2011
- Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain‐to‐pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophyMovement Disorders, 2010
- Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsyBrain, 2010
- What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy‐parkinsonism (PSP‐P)?Movement Disorders, 2010
- J. Clifford Richardson and 50 years of progressive supranuclear palsyNeurology, 2008
- Progressive Supranuclear Palsy: Pathology and GeneticsBrain Pathology, 2007
- Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)Neurology, 1996
- ParkinsonismNeurology, 1967